These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 25655639)

  • 21. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging.
    Johnson KM; Dowe DA
    J Am Coll Cardiol; 2014 Sep; 64(9):910-9. PubMed ID: 25169177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
    Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
    J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin therapy: not just used to lower cholesterol?
    Kronmann L; Hatfield C; Kronmann K
    Crit Care Nurs Q; 2007; 30(2):154-60. PubMed ID: 17356356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
    Igel M; Sudhop T; von Bergmann K
    Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation.
    Fukuda K; Matsumura T; Senokuchi T; Ishii N; Kinoshita H; Yamada S; Murakami S; Nakao S; Motoshima H; Kondo T; Kukidome D; Kawasaki S; Kawada T; Nishikawa T; Araki E
    Biochem Biophys Res Commun; 2015 Jan; 457(1):23-30. PubMed ID: 25529449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coenzyme Q10 and statins: biochemical and clinical implications.
    Littarru GP; Langsjoen P
    Mitochondrion; 2007 Jun; 7 Suppl():S168-74. PubMed ID: 17482884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins: potential new indications in inflammatory conditions.
    Endres M
    Atheroscler Suppl; 2006 Apr; 7(1):31-5. PubMed ID: 16503422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin use in heart failure: a cause for concern?
    Raina A; Pickering T; Shimbo D
    Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity?
    Tavintharan S; Ong CN; Jeyaseelan K; Sivakumar M; Lim SC; Sum CF
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):173-9. PubMed ID: 17610923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coenzyme Q10 and statins in heart failure: the dog that didn't bark.
    Felker GM
    J Am Coll Cardiol; 2010 Oct; 56(15):1205-6. PubMed ID: 20883927
    [No Abstract]   [Full Text] [Related]  

  • 33. One statin, two statins, three statins, more: similarities and differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Turkoski BB
    Orthop Nurs; 2011; 30(1):62-5; quiz 66-7. PubMed ID: 21278557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins in the treatment of chronic heart failure: biological and clinical considerations.
    van der Harst P; Voors AA; van Gilst WH; Böhm M; van Veldhuisen DJ
    Cardiovasc Res; 2006 Aug; 71(3):443-54. PubMed ID: 16730683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into mechanisms of statin-associated myotoxicity.
    Sirvent P; Mercier J; Lacampagne A
    Curr Opin Pharmacol; 2008 Jun; 8(3):333-8. PubMed ID: 18243052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Considerations for supplementing with coenzyme Q10 during statin therapy.
    Levy HB; Kohlhaas HK
    Ann Pharmacother; 2006 Feb; 40(2):290-4. PubMed ID: 16449543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users.
    Schaars CF; Stalenhoef AF
    Curr Opin Lipidol; 2008 Dec; 19(6):553-7. PubMed ID: 18957876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.
    Strey CH; Young JM; Molyneux SL; George PM; Florkowski CM; Scott RS; Frampton CM
    Atherosclerosis; 2005 Mar; 179(1):201-6. PubMed ID: 15721028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of statins in patients with non-ischemic heart failure.
    Laufs U; Wassmann S; Schackmann S; Heeschen C; Böhm M; Nickenig G
    Z Kardiol; 2004 Feb; 93(2):103-8. PubMed ID: 14963675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.